Anti-C5A Antibody: A New Approach for the Treatment of COVID-19

April 03, 2020 — JOINN’s clinical and bioanalytical teams participated in a research study highlighting a novel approach with therapeutic potential for the treatment of COVID-19. Read the full write-up here.